NCT01700985 A Study to Determine the Efficacy and Safety of 122-0551 in Subjects With Plaque Psoriasis Status COMPLETED Phase PHASE2
NCT01698333 Pharmacokinetics of 122-0551 and Its Effects on Adrenal Suppression Status COMPLETED Phase PHASE2
NCT01680159 A Clinical Study of Increased Dose of TA-650 in Patients With Psoriasis Status COMPLETED Phase PHASE3
NCT01677598 A Study to Evaluate Ustekinumab in Patients With Plaque Psoriasis in Asia-Pacific Countries Status COMPLETED Phase N/A
NCT01670513 A Phase 2 Dose Ranging, Evaluator-Blinded Study to Evaluate the Safety of Topical IDP-118 Status UNKNOWN Phase PHASE1/PHASE2
NCT01646073 Safety and Efficacy Study of Adalimumab in the Treatment of Plaque Psoriasis Status COMPLETED Phase PHASE3
NCT01634087 A Study of Escalating Doses of Itacitinib Administered Orally in Patients With Plaque Psoriasis Status COMPLETED Phase PHASE2
NCT01610596 A Study to Determine the Efficacy and Safety of Halobetasol Propionate Lotion 0.05% in Subjects With Plaque Psoriasis Status COMPLETED Phase PHASE2
NCT01566578 A Physiological Study on Downregulation of EGF-receptors in the Skin by Topical Exposition With EGF Status UNKNOWN Phase PHASE1
NCT01558310 A Study to Evaluate the Effectiveness of STELARA ™ (USTEKINUMAB) in the Treatment of Scalp Psoriasis Status UNKNOWN Phase PHASE4
NCT01483924 Study to Evaluate Apo805K1 in Subjects With Moderate to Severe Chronic Plaque Psoriasis Status COMPLETED Phase PHASE2
NCT01373567 A Phase IV Clinical Trial to Study the Safety, Tolerability and Efficacy of Tinefcon in Patients With Plaque Psoriasis Status COMPLETED Phase PHASE4
NCT01321164 Fumaric Acid Versus Fumaric Acid Plus Narrow Band Type B Ultraviolet (UVB) for Psoriasis Status COMPLETED Phase PHASE3
NCT01301157 Study to Investigate the Efficacy and the Safety of M518101 in Plaque Psoriasis Patients Status COMPLETED Phase PHASE2
NCT01279629 Open Clinical Study, Comparing Non-inferiority of Chronic Plaque Psoriasis Status SUSPENDED Phase N/A
NCT01251614 A Double Blind Study in Pediatric Subjects With Chronic Plaque Psoriasis, Studying Adalimumab vs. Methotrexate Status COMPLETED Phase PHASE3
NCT01235728 A Study to Evaluate and Compare the Efficacy and Pharmacokinetics of MK-0873 for the Treatment of Plaque Psoriasis (MK-0873-022) Status COMPLETED Phase PHASE1